Experimental Cell Therapy: 4 Children with Deadly Brain Cancer Still Alive Years Later
An experimental cell therapy for one of the deadliest brain tumors in children, intrinsic pontine glioma (DIPG), and other aggressive brain tumors has shown promising results. In a Phase 1 clinical trial at a US hospital, 33 children and young adults received 'tumor-associated antigen T cell therapy (TAA-T)', an experimental immunotherapy. Four of the treated…